Karo Healthcare AB - Strategic SWOT Analysis Review
Description
Karo Healthcare AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Karo Healthcare AB (Karo), formerly Karo Pharma AB, is a healthcare company. It specializes in branded medicines across key healthcare categories, including skin health, foot health, intimate health, digestive health, and vitamins & mineral supplements (VMS). Its portfolio features brands like E45, Locobase, Remescar, Pevaryl, Lamisil, Nutravita, Alpha Foods, and Lactocare among others. Karo’s products address common health issues such as dry skin, fungal infections, digestive discomfort, and foot care. The company operates primarily in Europe and the Nordic region. Karo is headquartered in, Stockholm, Sweden.
Karo Healthcare AB Key Recent Developments
Mar 16,2026: Karo Healthcare appoints Karine Martin as Chief Financial Officer
Sep 30,2025: Karo Healthcare Appoints Konstanze Gallinatus Chief Transformation Officer
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Karo Healthcare AB (Karo), formerly Karo Pharma AB, is a healthcare company. It specializes in branded medicines across key healthcare categories, including skin health, foot health, intimate health, digestive health, and vitamins & mineral supplements (VMS). Its portfolio features brands like E45, Locobase, Remescar, Pevaryl, Lamisil, Nutravita, Alpha Foods, and Lactocare among others. Karo’s products address common health issues such as dry skin, fungal infections, digestive discomfort, and foot care. The company operates primarily in Europe and the Nordic region. Karo is headquartered in, Stockholm, Sweden.
Karo Healthcare AB Key Recent Developments
Mar 16,2026: Karo Healthcare appoints Karine Martin as Chief Financial Officer
Sep 30,2025: Karo Healthcare Appoints Konstanze Gallinatus Chief Transformation Officer
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
31 Pages
- Section 1 - About the Company
- Karo Healthcare AB - Key Facts
- Karo Healthcare AB - Key Employees
- Karo Healthcare AB - Key Employee Biographies
- Karo Healthcare AB - Major Products and Services
- Karo Healthcare AB - History
- Karo Healthcare AB - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Karo Healthcare AB - Business Description
- Business Segment: Intimate & digestive health
- Performance
- Business Segment: Others
- Performance
- Business Segment: Skin & foot health
- Performance
- Business Segment: VMS
- Performance
- Geographical Segment: EU and UK
- Performance
- Geographical Segment: Nordics
- Performance
- Geographical Segment: Rest of World
- Performance
- Karo Healthcare AB - SWOT Analysis
- SWOT Analysis - Overview
- Karo Healthcare AB - Strengths
- Karo Healthcare AB - Weaknesses
- Karo Healthcare AB - Opportunities
- Karo Healthcare AB - Threats
- Karo Healthcare AB - Key Competitors
- Section 3 – Company’s Lifesciences Financial Deals and Alliances
- Karo Healthcare AB, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Karo Healthcare AB, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Karo Healthcare AB, Recent Deals Summary
- Section 4 – Company’s Recent Developments
- Mar 16, 2026: Karo Healthcare appoints Karine Martin as Chief Financial Officer
- Sep 30, 2025: Karo Healthcare Appoints Konstanze Gallinatus Chief Transformation Officer
- Section 5 – Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Karo Healthcare AB, Key Facts
- Karo Healthcare AB, Key Employees
- Karo Healthcare AB, Key Employee Biographies
- Karo Healthcare AB, Major Products and Services
- Karo Healthcare AB, History
- Karo Healthcare AB, Subsidiaries
- Karo Healthcare AB, Key Competitors
- Karo Healthcare AB, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Karo Healthcare AB, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Karo Healthcare AB, Recent Deals Summary
- List of Figures
- Karo Healthcare AB, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Karo Healthcare AB, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
